Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Administrative data

Key value for chemical safety assessment

Genetic toxicity in vitro

Description of key information

Ferrous gluconate is devoid of mutagenic properties and is thus classified as non-hazardous for this end point There are no studies for this endpoint on ferrous gluconate. Results of studies conducted with a structurally similar compound, Glucono-delta-lactone, are reported and used for read across. From this read across ferrous gluconate is classsified as non-hazardous for this endpoint. Read across justification summary is attached to the end point summary

Link to relevant study records

Referenceopen allclose all

Endpoint:
in vitro gene mutation study in bacteria
Remarks:
Type of genotoxicity: gene mutation
Type of information:
experimental study
Adequacy of study:
key study
Study period:
1974
Reliability:
2 (reliable with restrictions)
Rationale for reliability incl. deficiencies:
guideline study with acceptable restrictions
Qualifier:
equivalent or similar to guideline
Guideline:
OECD Guideline 471 (Bacterial Reverse Mutation Assay)
Deviations:
yes
Remarks:
Missing S. typhimurium strains TA98, TA100, and TA102 or E. coli strain WP2 uvrA; use of only 1 (in plate) and 2 (in suspension) concentrations instead of recommended 5.
GLP compliance:
no
Remarks:
Study predates GLP
Type of assay:
bacterial reverse mutation assay
Species / strain / cell type:
S. typhimurium TA 1535
Additional strain / cell type characteristics:
not applicable
Species / strain / cell type:
S. typhimurium TA 1537
Additional strain / cell type characteristics:
not applicable
Species / strain / cell type:
S. typhimurium TA 1538
Additional strain / cell type characteristics:
not applicable
Metabolic activation:
with and without
Metabolic activation system:
Lung, liver, and testes homogenates from adult male mice, rats, and monkeys
Test concentrations with justification for top dose:
0.50% (plate method) and 0.25% or 0.50% (suspension method)
Untreated negative controls:
no
Negative solvent / vehicle controls:
yes
Remarks:
Saline or <10% DMSO
True negative controls:
no
Positive controls:
yes
Positive control substance:
2-acetylaminofluorene
2-nitrofluorene
N-dimethylnitrosamine
ethylmethanesulphonate
other: Quinacrine Mustard
Species / strain:
S. typhimurium TA 1535
Metabolic activation:
with and without
Genotoxicity:
negative
Cytotoxicity / choice of top concentrations:
no cytotoxicity
Vehicle controls validity:
other: For plate tests, it is not clear if the vehicle controls were valid since no numerical results were reported. For suspension tests, vehicle controls appear to be valid.
Untreated negative controls validity:
not applicable
Positive controls validity:
other: For plate tests, it is not clear if the positive controls were valid since no numerical results were reported. For suspension tests, some of the positive control results do not appear to be valid.
Species / strain:
S. typhimurium TA 1537
Metabolic activation:
with and without
Genotoxicity:
negative
Cytotoxicity / choice of top concentrations:
no cytotoxicity
Vehicle controls validity:
other: For plate tests, it is not clear if the vehicle controls were valid since no numerical results were reported. For suspension tests, vehicle controls appear to be valid.
Untreated negative controls validity:
not applicable
Positive controls validity:
other: For plate tests, it is not clear if the positive controls were valid since no numerical results were reported. For suspension tests, some of the positive control results do not appear to be valid.
Species / strain:
S. typhimurium TA 1538
Metabolic activation:
with and without
Genotoxicity:
negative
Cytotoxicity / choice of top concentrations:
no cytotoxicity
Vehicle controls validity:
other: For plate tests, it is not clear if the vehicle controls were valid since no numerical results were reported. For suspension tests, vehicle controls appear to be valid.
Untreated negative controls validity:
not applicable
Positive controls validity:
other: For plate tests, it is not clear if the positive controls were valid since no numerical results were reported. For suspension tests, some of the positive control results do not appear to be valid.
Remarks on result:
other: all strains/cell types tested
Remarks:
Migrated from field 'Test system'.
Conclusions:
Interpretation of results (migrated information):
negative with metabolic activation
negative without metabolic activation

Glucono-delta-lactone, was negative both with or without metabolic activaton. However, some of the positive controls did not appear to be valid.
Executive summary:

Compound FDA 71 -72, glucono-delta-lactone, was negative both with or without metabolic activaton. However, some of the positive controls did not appear to be valid.

Endpoint:
genetic toxicity in vitro
Remarks:
Type of genotoxicity: gene mutation
Type of information:
experimental study
Adequacy of study:
key study
Study period:
1974
Reliability:
2 (reliable with restrictions)
Rationale for reliability incl. deficiencies:
guideline study with acceptable restrictions
Qualifier:
equivalent or similar to guideline
Guideline:
OECD Guideline 480 (Genetic Toxicology: Saccharomyces cerevisiae, Gene Mutation Assay)
Deviations:
yes
Remarks:
only 2 concentrations used; post-treatment incubation was 3-5 days; study done only once; positive control in the presence of S9 did not produce anticipated results so results deemed unreliable
GLP compliance:
no
Remarks:
Study predates GLP
Type of assay:
gene mutation assay in fungi
Species / strain / cell type:
Saccharomyces cerevisiae
Additional strain / cell type characteristics:
not applicable
Metabolic activation:
with and without
Metabolic activation system:
Lung, liver, and testes homogenates from adult male mice, rats, and monkeys (it was not reported whether or not an enzyme inducer was used)
Test concentrations with justification for top dose:
Concentrations reported as "high-dose" and "low-dose"
Untreated negative controls:
no
Negative solvent / vehicle controls:
yes
Remarks:
saline
True negative controls:
no
Positive controls:
yes
Positive control substance:
N-dimethylnitrosamine
ethylmethanesulphonate
Species / strain:
Saccharomyces cerevisiae
Metabolic activation:
with and without
Genotoxicity:
negative
Cytotoxicity / choice of top concentrations:
no cytotoxicity
Vehicle controls validity:
valid
Untreated negative controls validity:
not applicable
Positive controls validity:
not valid
Remarks on result:
other: all strains/cell types tested
Remarks:
Migrated from field 'Test system'.
Conclusions:
Interpretation of results (migrated information):
negative with metabolic activation
negative without metabolic activation

Glucono-delta-lacton, was not genetically active, either directly or in the presence of organ homogenates, in any of the in vitro assays employed in this evaluation
Executive summary:

Compound FDA 71 -72, glucono-delta-lacton, was not genetically active, either directly or in the presence of organ homogenates, in any of the in vitro assays employed in this evaluation

Endpoint conclusion
Endpoint conclusion:
no adverse effect observed (negative)

Genetic toxicity in vivo

Description of key information
Ferrous gluconate is devoid of mutagenic properties and is thus classified as non-hazardous for this end point Results of a study conducted with a structurally similar compoud, Glucono delta-lactone, are reported and used for read across in section 7.6.1. Glucono-delta-lactone, was not genetically active, either directly or in the presence of organ homogenates, in any of the in vitro assays employed in this evaluation. Read across justification summary is attached to the end point summary
Link to relevant study records
Reference
Endpoint:
in vivo mammalian germ cell study: gene mutation
Remarks:
Type of genotoxicity: gene mutation
Type of information:
experimental study
Adequacy of study:
supporting study
Reliability:
4 (not assignable)
Rationale for reliability incl. deficiencies:
documentation insufficient for assessment
GLP compliance:
not specified
Type of assay:
Drosophila SLRL assay
Species:
Drosophila melanogaster
Strain:
not specified
Sex:
male
Route of administration:
oral: unspecified
Duration of treatment / exposure:
10 days
Key result
Sex:
male
Genotoxicity:
negative

Ferrous Gluconate was not mutagenic at any exposure level used. Ferrous Gluconate was devoid of mutagenic properties.

Conclusions:
Interpretation of results (migrated information): negative
ferrous gluconate is devoid of mutagenic properties.
Executive summary:

This substantial paper is principally an introduction to the method. The Drosophila test is considered to check for mutations at 600 to 800 loci. It can detect both point mutagens and promutagens which require activation. Ferrous gluconate was one of 421 substances tested. The objective being to correlate known carcinogenic properties with this mutagenic end-point. The authors of the study, reviewed in this US-EPA report, found ferrous gluconate to be devoid of mutagenic properties.

Endpoint conclusion
Endpoint conclusion:
no adverse effect observed (negative)

Additional information

Justification for classification or non-classification

Results from in vivo studies confirmed that Iron Gluconate is classified as non-hazardous for this end point.

Results of an in vitro study conducted with a structurally similar compoud, Glucono delta-lactone, are reported and used for read across. Iron Gluconate did not contain any structural alerts for mutagenicity. The lack of alert and the physical-chemical properties indicate that iron gluconate should not be reactive to DNA.

 

Iron Gluconate consists of two gluconanic acids coordinated in an ionic bond with the ferrous ion. The molecule readily dissociates to form free gluconic acid which then cyclizes to form the corresponding lactone. D-glucono-1,5-lactone is the stable intermediate of the dissociation of ferrous gluconate and is therefore a reasonable surrogate for predicting the effect of the of the parent material . Neither the ferrous ion or D-glucono-1,5-lactoneare are genetically active (Lima et al, 2011). As such Iron Gluconate is considered to be not genetically active based on read-across. Full read across justification is attatched to this endpoint summary